Oceanpine Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Oceanpine Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 1, 2024	Orange Dental	$130.0M Series B	Oceanpine Capital, OrbiMed	3W Capital, Adjuvant Capital, AIHC Capital, Eight Roads Ventures, F-Prime Capital, Haitong International, Hillhouse Capital Group, MSA Capital, Superstring Capital
Aug 1, 2021	SVOLT	$1.6B Series B	Bank of China Group Investment	CCB International, China Renaissance, Country Garden Venture Capital, Guotou Chuangye, IDG Capital, JZ Capital, Shenzhen Capital Group, Sub-funds of National Fund for Technology Transfer and Commercialization, Xiaomi
Apr 26, 2021	Hepagene Therapeutics	$40.0M Series B	Loyal Valley Capital	Apricot Capital
Mar 30, 2021	Immune-Onc Therapeutics	$73.0M Onc Therapeutics - Series B	Dave Chenn	Northern Light Venture Capital, Octagon Capital, Sphera Healthcare, The Leukemia & Lymphoma Society, Vivo Capital
Feb 23, 2021	Teon Therapeutics	$30.0M Series A	Dave Chenn	Kaitai Capital, Lifespan Investments, Feng Deng, Oriza Ventures
Feb 1, 2021	LakeShore Biopharma	$130.0M Series B	OrbiMed, Dave Chenn	3W Capital, Adjuvant Capital, AIHC Capital, Eight Roads Ventures, Epiphron Capital, F-Prime Capital, Haitong International, Hillhouse Capital, MSA Capital, Superstring Capital
Sep 27, 2020	Creative Biosciences	$87.9M Series C	—	CDH Investments, IDG Capital, Shengyu Investment
Aug 13, 2020	hireEZ	$13.0M Series B	Dave Chenn	—
Aug 1, 2020	Triumvira Immunologics	$55.0M Series A	Northpond Ventures, Juergen Eckhardt	Brian Bloom, Centre for Commercialization of Cancer Immunotherapy
Mar 24, 2020	Apexigen	$65.0M Series C Extension	Decheng Capital, Oceanpine Capital	—
Oct 15, 2019	Ansun BioPharma	$7.9M Series B	Junson Capital, Korea Investment Partners, Oceanpine Capital	—
Oct 9, 2018	Rgenix	$40.0M Series C	Zhongjie Pu	Alexandria Venture Investments, Novo Holdings, Partnership Fund for New York City, Sofinnova Partners, WuXi AppTec
May 14, 2018	Ansun BioPharma	$85.0M Series A	Lilly Asia Ventures, Sinopharm Capital	3E Bioventures Capital, Joincap Investment, LYFE Capital, Matrix Partners China, VI Ventures, YuanMing Capital